Clinical Trial Update: Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the weight loss, physical function, and safety of Enobosarm in patients treated with GLP-1 receptor agonists, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Enobosarm (enobosarm)

Snippet

Sponsor: Veru Inc. | Conditions: Obesity & Overweight, Mobility Disability | Phase 2 | Status: RECRUITING